Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gel nail polish does not have a negative impact on the nail bacterial burden nor on the quality of hand hygiene with an alcohol-based hand rub.
Arreba P, Iglesias J, Ríos J, Herrera S, Marco DN, Montoya M, Brey M, Pitart C, Hernández-Meneses M, Cardozo C, García N, Sempere A, Verdejo M, Morata L, Bodro M, Garcia-Vidal C, García F, Soriano A, Martínez JA, Del Rio A; finger nail polish study group. Arreba P, et al. J Hosp Infect. 2024 Dec 17:S0195-6701(24)00408-0. doi: 10.1016/j.jhin.2024.12.006. Online ahead of print. J Hosp Infect. 2024. PMID: 39701497
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV.
Laguno M, de Lazzari E, Berrocal L, Inciarte A, Martínez-Rebollar M, de la Mora L, Torres B, Gonzalez-Cordón A, Chivite I, Foncillas A, Calvo J, Sempere A, Ambrosioni J, Blanco JL, Miro JM, Mallolas J, Martínez E. Laguno M, et al. Among authors: de la mora l. HIV Med. 2024 Dec;25(12):1308-1324. doi: 10.1111/hiv.13730. Epub 2024 Nov 7. HIV Med. 2024. PMID: 39508213 Free PMC article.
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study.
de Lazzari E, Nomah DK, Blanco JL, Rico N, Filella X, Egri N, Ruiz R, Marcos MA, Mosquera MDM, Alcamí J, Sánchez-Palomino S, Bruguera A, Hurtado C, Rovira C, Ambrosioni J, Chivite I, González-Cordón A, Inciarte A, Laguno M, Martínez-Rebollar M, de la Mora L, Torres B, Díaz Y, Martínez E, Mallolas J, Miro JM; Hospital Clinic HIV investigators. de Lazzari E, et al. Among authors: de la mora l. Int J Infect Dis. 2024 Dec;149:107266. doi: 10.1016/j.ijid.2024.107266. Epub 2024 Oct 18. Int J Infect Dis. 2024. PMID: 39423949 Free article.
Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study.
Martínez E, Foncillas A, Téllez A, Fernández S, Martínez-Nadal G, Rico V, Tomé A, Ugarte A, Rinaudo M, Berrocal L, De Lazzari E, Miró JM, Nicolás JM, Mallolas J, De la Mora L, Castro P. Martínez E, et al. Among authors: de la mora l. Infection. 2024 Oct 11. doi: 10.1007/s15010-024-02402-x. Online ahead of print. Infection. 2024. PMID: 39392586
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
Ugarte A, De La Mora L, De Lazzari E, Chivite I, Fernández E, Inciarte A, Laguno M, Ambrosioni J, Solbes E, Berrocal L, González-Cordón A, Martínez-Rebollar M, Foncillas A, Calvo J, Blanco JL, Martínez E, Mallolas J, Torres B. Ugarte A, et al. Among authors: de la mora l. J Antimicrob Chemother. 2024 Sep 3;79(9):2343-2353. doi: 10.1093/jac/dkae235. J Antimicrob Chemother. 2024. PMID: 39045754 Clinical Trial.
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis.
Chivite I, Berrocal L, de Lazzari E, Navadeh S, Lluis-Ganella C, Inciarte A, de la Mora L, González-Cordón A, Martínez-Rebollar M, Laguno M, Torres B, Blanco JL, Martínez E, Mallolas J, Ambrosioni J. Chivite I, et al. Among authors: de la mora l. J Antimicrob Chemother. 2024 Aug 1;79(8):1775-1783. doi: 10.1093/jac/dkae138. J Antimicrob Chemother. 2024. PMID: 38758191
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.
Inciarte A, de la Mora L, Huaier-Arriazu E, Torres B, Cañizares S, Zamora E, Laguno M, Gonzalez-Cordón A, Foncillas A, Chivite I, Calvo J, Ambrosioni J, Martínez E, Blanco JL, Miro JM, Martinez-Rebollar M, Mallolas J. Inciarte A, et al. Among authors: de la mora l. Infect Dis Ther. 2024 Apr;13(4):647-658. doi: 10.1007/s40121-024-00962-x. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570445 Free PMC article.
Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020.
Nomah DK, Jamarkattel S, Bruguera A, Moreno-Fornés S, Díaz Y, Alonso L, Aceitón J, Llibre JM, Domingo P, Saumoy M, Homar F, Fanjul F, Navarro J, de la Mora L, Knobel H, Orti A, Martin-Iguacel R, Miró JM, Casabona J, Reyes-Urueña J. Nomah DK, et al. Among authors: de la mora l. Open Forum Infect Dis. 2024 Mar 8;11(4):ofae132. doi: 10.1093/ofid/ofae132. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38560603 Free PMC article.
Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project.
Bruguera A, Egea-Cortés L, Mesías-Gazmuri J, Palacio-Vieira J, Forero CG, Miranda C, Saumoy M, Fernández E, Navarro G, Orti A, Miró JM, Casabona J, Reyes-Urueña J; PISCS Study Group. Bruguera A, et al. HIV Med. 2024 Apr;25(4):424-439. doi: 10.1111/hiv.13590. Epub 2023 Dec 13. HIV Med. 2024. PMID: 38092529
54 results